ArticleJournal of surgical oncology2026
Comparative Severe Complications After Laparoscopic Pancreatoduodenectomy in PDAC vs Non-PDAC Periampullary Cancer: A Retrospective Cohort Study.
Article in Journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative Severe Complications After Laparoscopic Pancreatoduodenectomy in PDAC vs Non-PDAC Periampullary Cancer: A Retrospective Cohort Study.Journal of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionLaparoscopic pancreatoduodenectomy (LPD) offers the potentially clinical benefit for patients presenting with periampullary tumors. The aim of this study is to evaluate postoperative clinical outcomes among patients undergoing LPD for periampullary cancer. STUDY
designWe retrospectively reviewed and analyzed 574 consecutive patients received LPD for periampullary cancer at our institution between April 2011 and August 2024. Data collected included preoperative, perioperative, and postoperative information.
resultsAmong 574 patients undergoing LPD for periampullary cancer, 311 (54.2%) pathologically diagnosed with pancreatic ductal adenocarcinoma (PDAC) and 263 (45.8%) had non-PDAC periampullary cancer. Compared with PDAC, non-PDAC patients experienced significantly higher rates of major morbidity (16.7% vs 10.9%, p = 0.043), including postoperative pancreatic fistula (p = 0.001), abdominal infection (p = 0.032), and reoperation (p = 0.021). Multivariate analysis identified age ≥ 65 years (OR 1.803, 95%CI: 1.092 ~ 2.978), prolonged operative time (OR 1.004, 95%CI: 1.001 ~ 1.006), and non-PDAC pathology (OR 1.664, 95%CI: 1.014 ~ 2.731) as independent risk factors for severe complications, while pylorus preservation was protective (OR 0.460, 95%CI: 0.264 ~ 0.803).
conclusionPostoperative morbidity after LPD varies by periampullary cancer subtype, with non-PDAC patients at greater risk of severe complications. Older age, prolonged operative time, and non-PDAC pathology were independent predictors of severe complications, whereas pylorus preservation conferred a protective effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.